The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 29, 2009
Filed:
Dec. 26, 2007
Xin Chen, San Ramon, CA (US);
Peng Cheng, Union City, CA (US);
L. Edward Clemens, Davis, CA (US);
Jeffrey D. Johnson, Moraga, CA (US);
Jingyuan MA, Sunnyvale, CA (US);
Alison Murphy, Milpitas, CA (US);
Imad Nashashibi, San Jose, CA (US);
Christoper J. Rabbat, San Jose, CA (US);
Jiangao Song, Sunnyvale, CA (US);
Maria E. Wilson, San Francisco, CA (US);
Yan Zhu, Foster City, CA (US);
Zuchun Zhao, Pleasanton, CA (US);
Xin Chen, San Ramon, CA (US);
Peng Cheng, Union City, CA (US);
L. Edward Clemens, Davis, CA (US);
Jeffrey D. Johnson, Moraga, CA (US);
Jingyuan Ma, Sunnyvale, CA (US);
Alison Murphy, Milpitas, CA (US);
Imad Nashashibi, San Jose, CA (US);
Christoper J. Rabbat, San Jose, CA (US);
Jiangao Song, Sunnyvale, CA (US);
Maria E. Wilson, San Francisco, CA (US);
Yan Zhu, Foster City, CA (US);
Zuchun Zhao, Pleasanton, CA (US);
Metabolex Inc., Hayward, CA (US);
Abstract
Compounds, compositions, and methods relating to 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine or a pharmaceutically acceptable salt thereof are provided for the treatment of Type II diabetes and other diseases associated with poor glycemic control.